Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Debasish Roychowdhury"'
Autor:
Eric P. Winer, Paolo Paoletti, Debasish Roychowdhury, Cristina Oliva, Denise Zembryki, Klaudia Steplewski, Bernie Dharan, Stephen D. Rubin, Joanne L. Blum, Adam Brufsky, Denise Yardley, Andrew Wardley, Stefania Gori, Sibylle Loibl, Eva Ciruelos, Richard Greil, Minetta C. Liu, Henri Roché, Hans-Joachim Stemmler, Christos Christodoulou, Dominique Lossignol, Devchand Paul, Véronique Diéras, Nancy U. Lin
Purpose: Brain metastases develop in one third of patients with advanced HER2+ breast cancer. Effective therapy for patients with central nervous system (CNS) progression after cranial radiation is extremely limited and represents a major clinical ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b28dc6c170e4838f473d40e9f1c8e4f
https://doi.org/10.1158/1078-0432.c.6517522
https://doi.org/10.1158/1078-0432.c.6517522
Autor:
Eric P. Winer, Paolo Paoletti, Debasish Roychowdhury, Cristina Oliva, Denise Zembryki, Klaudia Steplewski, Bernie Dharan, Stephen D. Rubin, Joanne L. Blum, Adam Brufsky, Denise Yardley, Andrew Wardley, Stefania Gori, Sibylle Loibl, Eva Ciruelos, Richard Greil, Minetta C. Liu, Henri Roché, Hans-Joachim Stemmler, Christos Christodoulou, Dominique Lossignol, Devchand Paul, Véronique Diéras, Nancy U. Lin
Supplementary Data from Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d13815d0dc2df0ff0ad271f6254216
https://doi.org/10.1158/1078-0432.22440151.v1
https://doi.org/10.1158/1078-0432.22440151.v1
Autor:
Ruth Seurinck, Bastiaan Maes, Jozefien Declercq, Thomas Malfait, Levi Hoste, Ingel K. Demedts, Hans Slabbynck, Alessandro Sette, Leslie Naesens, Sam Dupont, Linos Vandekerckhove, Julie Deckers, Eva Van Braeckel, Yannick Vande Weygaerde, Stefaan J. Vandecasteele, Jozefien De Clercq, Filomeen Haerynck, Debasish Roychowdhury, Sabine Allard, Liesbet Martens, Nincy Debeuf, Simon Tavernier, Daniela Weiskopf, Elisabeth De Leeuw, Cedric Bosteels, Victor Bosteels, Niels Vandamme, Martin Guilliams, Pieter Depuydt, Bart N. Lambrecht, Karel Van Damme
Granulocyte-macrophage colony-stimulating factor (GM-CSF) instructs monocytes to differentiate into alveolar macrophages (AM) that preserve lung homeostasis. By comparing AM development in mouse and human, we discovered that COVID-19 patients showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d50859aab082c13e82e7aa27f584fee
https://doi.org/10.21203/rs.3.rs-959220/v1
https://doi.org/10.21203/rs.3.rs-959220/v1
Autor:
Takeharu Yamanaka, Shun Lu, Jolanda Paolini, Jin Ji Yang, Yi-Long Wu, Takashi Seto, Toshiaki Takahashi, Allison Kemner, Tiziana Usari, Dong Wan Kim, Keith D. Wilner, Myung-Ju Ahn, Koichi Goto, Jianying Zhou, Noboru Yamamoto, Debasish Roychowdhury, James Chih-Hsin Yang
Publikováno v:
Journal of Clinical Oncology. 36:1405-1411
Purpose Approximately 1% to 2% of non–small-cell lung cancers (NSCLCs) harbor a c-ros oncogene 1 ( ROS1) rearrangement. Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and MET, has shown marked antitumor activity in a small expa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc96b75cb58226a2ed944493bb8b9b94
https://doi.org/10.1200/jco.2017.75.5587
https://doi.org/10.1200/jco.2017.75.5587
Autor:
Jeffrey J. Sussman, M. M. Safa, Patricia Rose, Kevin P. Redmond, John A. Howington, Laura E. James, Syed A. Ahmad, Irfan Firdaus, Abdul Rahman Jazieh, Andrew M. Lowy, Debasish Roychowdhury, Michael F. Reed
Publikováno v:
American Journal of Clinical Oncology. 29:555-561
Objective: To evaluate the feasibility and efficacy of sequential neoadjuvant chemotherapy, chemoradiation, and surgery in patients with locally advanced esophageal cancer. Patients and Methods: There were 29 patients who received paclitaxel 150 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1831a3a05ae8eefe924dc4b3444f7bd7
https://doi.org/10.1097/01.coc.0000233997.36073.8e
https://doi.org/10.1097/01.coc.0000233997.36073.8e
Autor:
Debasish Roychowdhury, Michael Lahn
Publikováno v:
Seminars in Oncology. 30:30-33
As our understanding of the biology of cancer increases, the attempts to target specific molecules associated with the promotion of cancer are accelerating. One of the targets currently being studied as an important tumor-promoting factor is protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6065cd3291b11fccd22f12a67bccd9
https://doi.org/10.1016/s0093-7754(03)70143-2
https://doi.org/10.1016/s0093-7754(03)70143-2
Publikováno v:
Investigational New Drugs. 20:311-315
Background: Serious pulmonary toxicity(SPT) has recently been noted withgemcitabine-based therapy (G). However,the incidence of SPT has not been fullyevaluated. This retrospective reviewestimates the incidence of, and the factorsinfluencing, SPT with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274b17580bd116f9884b8fa1ad257e77
https://doi.org/10.1023/a:1016214032272
https://doi.org/10.1023/a:1016214032272
Autor:
Jin-Ji Yang, Jolanda Paolini, Koichi Goto, Debasish Roychowdhury, Takashi Seto, James CHYang, Yi-Long Wu, Jianying Zhou, Dong Wan Kim, Shun Lu
Publikováno v:
Annals of Oncology. 28:ix91
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93d53c02e54390baed6bae3e4df663f9
https://doi.org/10.1093/annonc/mdx697.074
https://doi.org/10.1093/annonc/mdx697.074
Publikováno v:
Acta Cytologica. 43:847-852
BACKGROUND: Fine needle aspiration (FNA) biopsy can be used to reliably classify most conditions involving lymph nodes or, at least, significantly reduce the differential diagnosis. CASE: A 70-year-old male presented with an ulcerated mass arising fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2de5abb80efe1c89081f33128a38c05
https://doi.org/10.1159/000331301
https://doi.org/10.1159/000331301
Autor:
Takeharu Yamanaka, Toshiaki Takahashi, Jin-Ji Yang, Takashi Seto, Allison Kemner, Yi-Long Wu, Dong Wan Kim, Noboru Yamamoto, Shun Lu, James Chih-Hsin Yang, Debasish Roychowdhury, Keith D. Wilner, Myung-Ju Ahn, Jolanda Paolini, Koichi Goto
Publikováno v:
Journal of Clinical Oncology. 34:9022-9022
9022Background: Approximately 1–2% of NSCLCs harbor a rearrangement of the ROS1 gene, an oncogene for which screening is difficult due to its low incidence. Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), ROS1, and MET, showed marked
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f42bfb36680654b73b9ff226bd18aad
https://doi.org/10.1200/jco.2016.34.15_suppl.9022
https://doi.org/10.1200/jco.2016.34.15_suppl.9022